Search

Holly G. Schnizer

Examiner (ID: 1847)

Most Active Art Unit
1653
Art Unit(s)
1653, 1656, 1652, 2899
Total Applications
277
Issued Applications
128
Pending Applications
73
Abandoned Applications
76

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6683859 [patent_doc_number] => 20030119723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides' [patent_app_type] => new [patent_app_number] => 10/287195 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18643 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119723.pdf [firstpage_image] =>[orig_patent_app_number] => 10287195 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/287195
Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides Nov 3, 2002 Abandoned
Array ( [id] => 6846837 [patent_doc_number] => 20030166004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Endothelial-cell binding peptides for diagnosis and therapy' [patent_app_type] => new [patent_app_number] => 10/286457 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 28214 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166004.pdf [firstpage_image] =>[orig_patent_app_number] => 10286457 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/286457
Endothelial-cell binding peptides for diagnosis and therapy Oct 31, 2002 Abandoned
Array ( [id] => 6669402 [patent_doc_number] => 20030114386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Hexa-, hepta-, and octapeptides having antiangiogenic activity' [patent_app_type] => new [patent_app_number] => 10/283553 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15822 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114386.pdf [firstpage_image] =>[orig_patent_app_number] => 10283553 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/283553
Hexa-, hepta-, and octapeptides having antiangiogenic activity Oct 29, 2002 Issued
Array ( [id] => 6843606 [patent_doc_number] => 20030148953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Inactivation resistant factor VIII' [patent_app_type] => new [patent_app_number] => 10/283648 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 17913 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148953.pdf [firstpage_image] =>[orig_patent_app_number] => 10283648 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/283648
Inactivation resistant factor VIII Oct 28, 2002 Abandoned
Array ( [id] => 6861619 [patent_doc_number] => 20030092627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Pharmaceutical composition comprising a factor VIIa and a factor XIII' [patent_app_type] => new [patent_app_number] => 10/271278 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11858 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092627.pdf [firstpage_image] =>[orig_patent_app_number] => 10271278 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/271278
Pharmaceutical composition comprising a factor VIIa and a factor XIII Oct 14, 2002 Abandoned
Array ( [id] => 7206451 [patent_doc_number] => 20040087498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Modified factor VII' [patent_app_type] => new [patent_app_number] => 10/263205 [patent_app_country] => US [patent_app_date] => 2002-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17479 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087498.pdf [firstpage_image] =>[orig_patent_app_number] => 10263205 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/263205
Modified factor VII Sep 30, 2002 Abandoned
Array ( [id] => 6801201 [patent_doc_number] => 20030096366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Method for production of recombinant proteins in eukaryote cells' [patent_app_type] => new [patent_app_number] => 10/254394 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9834 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096366.pdf [firstpage_image] =>[orig_patent_app_number] => 10254394 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/254394
Method for production of recombinant proteins in eukaryote cells Sep 24, 2002 Abandoned
Array ( [id] => 6788333 [patent_doc_number] => 20030139572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Novel compounds' [patent_app_type] => new [patent_app_number] => 10/239663 [patent_app_country] => US [patent_app_date] => 2002-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14668 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139572.pdf [firstpage_image] =>[orig_patent_app_number] => 10239663 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/239663
Novel compounds Sep 23, 2002 Abandoned
Array ( [id] => 6656655 [patent_doc_number] => 20030077753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Diglycosylated erythropoietin' [patent_app_type] => new [patent_app_number] => 10/241356 [patent_app_country] => US [patent_app_date] => 2002-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5573 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077753.pdf [firstpage_image] =>[orig_patent_app_number] => 10241356 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/241356
Diglycosylated erythropoietin Sep 10, 2002 Issued
Array ( [id] => 6861131 [patent_doc_number] => 20030092139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Process for the fermentative preparation of L-amino acids using coryneform bacteria' [patent_app_type] => new [patent_app_number] => 10/212219 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6084 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092139.pdf [firstpage_image] =>[orig_patent_app_number] => 10212219 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/212219
Process for the fermentative preparation of L-amino acids using coryneform bacteria Aug 5, 2002 Abandoned
Array ( [id] => 6706319 [patent_doc_number] => 20030153053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Methods for altering polyketide synthase genes' [patent_app_type] => new [patent_app_number] => 10/214424 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4173 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153053.pdf [firstpage_image] =>[orig_patent_app_number] => 10214424 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/214424
Methods for altering polyketide synthase genes Aug 5, 2002 Abandoned
Array ( [id] => 6683863 [patent_doc_number] => 20030119727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'FVIIa antagonists' [patent_app_type] => new [patent_app_number] => 10/202915 [patent_app_country] => US [patent_app_date] => 2002-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26822 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119727.pdf [firstpage_image] =>[orig_patent_app_number] => 10202915 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/202915
FVIIa antagonists Jul 24, 2002 Issued
Array ( [id] => 761356 [patent_doc_number] => 07012132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-14 [patent_title] => 'Modified factor VIII' [patent_app_type] => utility [patent_app_number] => 10/187319 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 31128 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/012/07012132.pdf [firstpage_image] =>[orig_patent_app_number] => 10187319 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/187319
Modified factor VIII Jun 27, 2002 Issued
Array ( [id] => 7199367 [patent_doc_number] => 20040086501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Protein having activity as an angiogenesis modulator' [patent_app_type] => new [patent_app_number] => 10/019065 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8813 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086501.pdf [firstpage_image] =>[orig_patent_app_number] => 10019065 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/019065
Protein having activity as an angiogenesis modulator May 30, 2002 Abandoned
10/031947 Multi-dose erythropoietin formulations May 14, 2002 Abandoned
Array ( [id] => 6656653 [patent_doc_number] => 20030077751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Zvwf1: a member of the von Willebrand factor type a domain superfamily' [patent_app_type] => new [patent_app_number] => 10/127101 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30001 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077751.pdf [firstpage_image] =>[orig_patent_app_number] => 10127101 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/127101
Zvwf1: a member of the von Willebrand factor type a domain superfamily Apr 18, 2002 Abandoned
Array ( [id] => 758032 [patent_doc_number] => 07015193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-21 [patent_title] => 'Compositions and methods to control bleeding' [patent_app_type] => utility [patent_app_number] => 10/125950 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 26 [patent_no_of_words] => 13983 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015193.pdf [firstpage_image] =>[orig_patent_app_number] => 10125950 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/125950
Compositions and methods to control bleeding Apr 18, 2002 Issued
Array ( [id] => 6701484 [patent_doc_number] => 20030224364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci' [patent_app_type] => new [patent_app_number] => 10/107431 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 46176 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224364.pdf [firstpage_image] =>[orig_patent_app_number] => 10107431 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/107431
Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci Mar 27, 2002 Abandoned
Array ( [id] => 6377606 [patent_doc_number] => 20020119487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Human stem cell antigen 2' [patent_app_type] => new [patent_app_number] => 10/101747 [patent_app_country] => US [patent_app_date] => 2002-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12612 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119487.pdf [firstpage_image] =>[orig_patent_app_number] => 10101747 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/101747
Human stem cell antigen 2 Mar 20, 2002 Abandoned
Array ( [id] => 6158784 [patent_doc_number] => 20020147148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Insecticidal protein toxins from xenorhabdus' [patent_app_type] => new [patent_app_number] => 10/078968 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16043 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147148.pdf [firstpage_image] =>[orig_patent_app_number] => 10078968 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/078968
Insecticidal protein toxins from xenorhabdus Feb 18, 2002 Abandoned
Menu